Márcio Diniz-Freitas, Javier Fernández-Feijoo, Paula Fernández-Montenegro, Antonio González-Mosquera, Emma Vázquez-García, Pedro Diz-Dios
Oral Medicine and Oral Surgery Unit, Faculty of Medicine and Dentistry, University of Santiago de Compostela, Santiago de Compostela, Spain. marcio.diniz@usc.es
Medicina oral, patología oral y cirugía bucal 2012 JulTo evaluate the criteria for the prescription of oral bisphosphonates (OB) in a series of women with osteoporosis referred for tooth extraction. The study included 38 postmenopausal women on treatment with OBs. The following variables were analysed: age, weight, height, type of OB and duration of treatment, bone densitometry and risk factors for osteoporosis. In addition, the osteoporosis self-assessment tool (OST) was administered and collagen type I C-telopeptide (CTX) levels were measured. Bone densitometry had only been performed in six patients (15.7%) before starting OB treatment. Based on the results of the OST, nine (23.6%) of the participants presented a low risk of osteoporosis. CTX levels were measured in 23 patients: 11 (47.8%) presented values below 150 pg/ml. Although all patients in the present series were on treatment with OBs, a large percentage did not satisfy the criteria for the initiation of treatment for postmenopausal osteoporosis.
Márcio Diniz-Freitas, Javier Fernández-Feijoo, Paula Fernández-Montenegro, Antonio González-Mosquera, Emma Vázquez-García, Pedro Diz-Dios. Criteria for the prescription of oral bisphosphonates for the treatment of osteoporosis in a series of women referred for tooth extraction. Medicina oral, patología oral y cirugía bucal. 2012 Jul;17(4):e601-4
PMID: 22322496
View Full Text